Log in
Enquire now
‌

US Patent 11203640 Checkpoint inhibitor bispecific antibodies

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
112036400
Patent Inventor Names
Yiwen Li0
Igor Edmondo Paolo D'Angelo0
Michael Dewain Kalos0
Yang Shen0
Dale Lincoln Ludwig0
Gregory D Plowman0
Date of Patent
December 21, 2021
0
Patent Application Number
160299790
Date Filed
July 9, 2018
0
Patent Primary Examiner
‌
Brad Duffy
0
Patent abstract

The present invention relates to antibodies that are heterodimeric and bind human PD-L1 and human PD-1, and may be useful for treating cancer alone and in combination with chemotherapy and other cancer therapeutics.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11203640 Checkpoint inhibitor bispecific antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.